Corneal transplant surgery for keratoconus and the effect of surgeon experience on deep anterior lamellar keratoplasty outcomes.

Authors:

Shivani A Kasbekar Mark N A Jones Sajjad Ahmad Daniel F P Larkin Stephen B Kaye

Am J Ophthalmol 2014 Dec 28;158(6):1239-46. Epub 2014 Aug 28.

St Paul's Eye Unit, 8X Link, Royal Liverpool University Hospital, Liverpool, United Kingdom. Electronic address:

Purpose: To investigate graft survival and surgical experience on clinical outcome following deep anterior lamellar keratoplasty (DALK).

Design: Multicenter cohort study.

Methods: The United Kingdom Transplant Database was used to identify patients who had undergone a first DALK or penetrating keratoplasty (PKP) for keratoconus. Data were collected at the time of surgery and at 1, 2, and 5 years postoperatively. Graft survival, best-corrected visual acuity, and refractive error were analyzed for 3 consecutive time periods. DALK outcomes were analyzed according to surgeon experience.

Results: A total of 4521 patients were included. Graft survival was 92% (95% CI: 90-92) for PKP and 90% (95% CI: 88-92) for DALK (P = .09). For corneal transplants undertaken in the periods 1999-2002, 2002-2005, and 2005-2007, graft survival was 90%, 92%, and 88% following DALK, and 93%, 91%, and 92% following PKP, respectively. There was no evidence of a difference between surgeons in terms of case mix (P = .4) or outcome (P = .2). Surgeon experience, in terms of the number of previous DALK undertaken, had no significant effect on outcome. A donor recipient trephine size disparity of 0.5 mm was associated with an increased risk of graft failure for both DALK (P = .03) and PKP (P = .002), whereas ocular surface disease was a significant risk factor for DALK (P = .04) but not PKP.

Conclusions: There has been little change in graft survival for DALK and PKP over the past decade. Ocular surface disease is an important risk factor for graft failure following DALK. A surgical learning curve for DALK could not be demonstrated in terms of clinical outcome.

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ajo.2014.08.029	DOI Listing

December 2014

Publication Analysis

Top Keywords

lamellar keratoplasty

Keyword Occurance

Similar Publications

Impact of sarcopenia on clinical outcomes of patients undergoing simultaneous liver and kidney transplantation: a cohort study.

Authors:

Alessandra Mazzola Raffaele Brustia Bianca Magro Muhammad Atif Nassera Ouali Jérôme Tourret Benoit Barrou Olivier Scatton F Conti

Clin Res Hepatol Gastroenterol 2021 Apr 10:101692. Epub 2021 Apr 10.

APHP, Unité Médicale de Transplantation Hépatique Hôpital Pitié Salpêtrière, Boulevard de l'Hôpital 47-83, 75013 Paris, France; Sorbonne Université, INSERM, Centre de recherche Saint-Antoine (CRSA), Paris, France; Sorbonne Université, INSERM, Institute of Cardiometabolisme and Nutrition (ICAN), Paris, France.

Background: The impact of sarcopenia in patients undergoing simultaneous liver and kidney transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort-study was to evaluate the impact of sarcopenia on the clinical outcomes.

Methods: Between 2003 and 2018, 79 patients underwent SLKT. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Temporal Trends in the Quality of Deceased Donor Kidneys and Kidney Transplant Outcomes in Europe: an analysis by the ERA-EDTA Registry.

Authors:

Maria Pippias Vianda S Stel Miha Arnol Frederike Bemelman Stefan P Berger Jadranka Buturovic Ponikvar Reinhard Kramar Ángela Magaz Maurizio Nordio Hessel Peters-Sengers Anna Varberg Reisæter Søren S Sørensen Ziad A Massy Kitty J Jager

Nephrol Dial Transplant 2021 Apr 12. Epub 2021 Apr 12.

Kitty J. Jager Professor, : ERA, -EDTA Registry, Department of Medical Informatics, Amsterdam, UMC-location, AMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the, Netherlands.

Background: We investigated ten-year trends in deceased donor kidney quality expressed as the kidney donor risk index (KDRI) and subsequent effects on survival outcomes in a European transplant population.

Methods: Time trends in the crude and standardised KDRI between 2005-2015, by recipient age, sex, diabetic status, and country were examined in 24,177 adult kidney transplant recipients in seven European countries. We determined five-year patient and graft survival probabilities and the risk of death and graft loss by transplant cohort (cohort 1: 2005-2006, cohort 2: 2007-2008, cohort 3: 2009-2010) and KDRI quintile. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Metformin therapy and risk of cancer in patients after heart transplantation.

Authors:

H Bedanova V Horvath J Ondrasek J Krejci P Dobsak P Nemec

Bratisl Lek Listy 2021 ;122(5):305-309

Background: Diabetes mellitus (DM) and malignancy are recognized among the most common complications increasing mortality in patients after heart transplantation (HTx). Clinical trials have shown a higher risk for different types of tumours in diabetic patients. This risk is potentiated by immunosuppressive therapy in transplant patients. Read More

View Article and Full-Text PDF

January 2021

Similar Publications

Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.

Authors:

Jeremy L Ramdial Rohtesh S Mehta Rima M Saliba Amin M Alousi Qaiser Bashir Chitra Hosing Partow Kebriaei Amanda L Olson Betul Oran Muzaffar H Qazilbash Samer A Srour Borje S Andersson Richard E Champlin Uday Popat

Bone Marrow Transplant 2021 Apr 12. Epub 2021 Apr 12.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Despite low nonrelapse mortality (NRM) at day 100 after allogeneic hematopoietic cell transplantation (HCT), NRM at 1 year remains substantial. In this study, we retrospectively analyzed 199 patients who were treated on a phase II clinical trial assessing safety and efficacy of myeloablative fractionated busulfan and fludarabine conditioning regimen for hematologic malignancies. The goal of the study was to identify factors associated with NRM occurring between days 101 and 365 post-HCT and generate a hypothesis for future studies to reduce the risk of NRM at 1 year. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Improved transplant outcomes with myeloablative conditioning for hemophagocytic lymphohistiocytosis in HLA-matched and mismatched donors: a national multicenter retrospective study.

Authors:

Yarden Greental Ness Amir A Kuperman Jerry Stein Joanne Yacobovich Ehud Even-Or Irina Zaidman Aharon Gefen Neta Nevo Bernice Oberman Amos Toren Polina Stepensky Bella Bielorai Elad Jacoby

Bone Marrow Transplant 2021 Apr 12. Epub 2021 Apr 12.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

We report the results of national retrospective study of 45 children with hemophagocytic lymphohistiocytosis (HLH) who underwent allogeneic hematopoietic stem-cell transplantation (HSCT) in Israel between the years 2000-2018. Donors were either HLA-matched (n = 26), partially mismatched (n = 7), haploidentical (n = 8), or cord-blood (n = 4). Myeloablative conditioning (MAC) was used in 20 procedures, and reduced-intensity conditioning (RIC) in 25. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Search Our Scientific Publications & Authors